Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Gastroenterology
Hospital Medicine
Questions discussed in this category
What adjunctive therapies beyond an antisecretory agent (e.g., PPI, H2RA, etc.) do you find most helpful in managing the acute symptoms of PUD?
For example, do you routinely supplement with calcium carbonate, magnesium hydroxide, aluminum hydroxide, simethicone, sucralfate, etc.?
1 Answer available
What is your approach to duration of fidaxomicin in a patient receiving treatment for first C difficile infection while also receiving concurrent antibiotics for an infection?
Do you extend the course of fidaxomicin past initial 10 days to at least 3-7 days after completion of antibiotics?
1 Answer available
How do you determine whether to limit volume removal during therapeutic paracentesis in a patient without acute or chronic kidney disease?
1 Answer available
What is your approach to secondary prophylaxis for C difficile infection during concomitant antibiotic use in a patient with a history of C difficile infection?
1 Answer available
Should platelet transfusions be considered for anti-platelet agent reversal in patients with major bleeding?
2 Answers available
Do you continue antiplatelet/anticoagulant therapy in patients with hemodynamically stable diverticular bleeding to improve localization and treatment of source of bleeding?
3 Answers available
Do you routinely recommend diagnostic endoscopy for patients with persistent enterococcus bacteremia despite receiving adequate antimicrobial therapy and no clear nidus?
Rogers & Rice, PMID 38018162
2 Answers available
Is there a serum ammonium level for which you recommend initiation of dialysis in a patient with hepatic encephalopathy?
2 Answers available
What is your approach to treatment of patients with fulminant C difficile infection who required ileostomy creation or colectomy?
Is there a role for oral vancomycin in these patients, or is oral vancomycin redundant if other routes of administration are being used (i.e intracolo...
1 Answer available
Which patients with cirrhosis and portal hypertension are ideal candidates to undergo TIPS to reduce perioperative risk in anticipation of an elective surgery?
1 Answer available
How would you approach management of a patient with a medium-to-large vessel vasculitis who developed perforation of the stomach and colon on steroids and cyclophosphamide?
Vasculitis involving aorta, subclavian, common carotid, SMA, IMA, renal artery, and celiac artery.
1 Answer available
Do you avoid terlipressin for patients with hepatorenal syndrome who have a serum sodium level less than 125 mEq/L?
2 Answers available
How long should surgery be delayed in a patient with localized, resectable pancreatic cancer who developed acute pancreatitis following EUS guided biopsy?
And if delayed, should chemotherapy be started?
2 Answers available
23815
20036
23133
17500
8566
21586
21444
22723
19714
21601
20758
20790
18705
Papers discussed in this category
Lancet, 2016 May 10
Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial.
Microbes and infection, 2024 May 06
Secondary prophylaxis for Clostridioides difficile infection for patients on non-C. difficile antibiotics: a retrospective cohort study.
American journal of clinical oncology, 2023 Dec 22
Executive Summary of the American Radium Society Appropriate Use Criteria for Neoadjuvant Therapy for Nonmetastatic Pancreatic Adenocarcinoma: Systematic Review and Guidelines.
The New England journal of medicine, 2021 Mar 04
Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome.
Clinical journal of the American Society of Nephrology : CJASN, 2023 Oct 17
How We Treat Hyperammonemia in Acute Liver Failure.
The American journal of medicine, 1991 Aug 08
Treatment of peptic ulcer disease with sucralfate: a review.
Gut, 1990 Jul
Sucralfate in the treatment and prevention of gastric ulcer: multicentre double blind placebo controlled study.
Related Topics in Gastroenterology
Radiation Oncology
Gynecologic Oncology
Palliation
Gastrointestinal Cancers
Genitourinary Cancers
Melanoma/Skin Cancer
Pediatric Hematology/Oncology
Thoracic Malignancies
Esophageal Cancer
Medical Oncology